Key Takeaways
SES AI Corporation is facing a securities fraud lawsuit after its stock plunged 30 percent on March 5, 2026, following the release of a weak 2026 revenue forecast.
"According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) SES AI overstated its business prospects by materially overstating the expected results that could be achieved by deals with companies that have limited or no operations; (2) SES AI created an appearance of revenue by purchasing services in exchange for purchases of Molecular Universe," the complaint filed by Rosen Law Firm states.
The class period for the lawsuit covers investors who purchased SES AI securities between January 29, 2025, and March 4, 2026. The lawsuits were filed by several firms, including The Schall Law Firm, Block & Leviton, Rosen Law Firm, and Robbins LLP.
The legal action follows a significant drop in the company's stock value, which has brought increased scrutiny on its financial reporting and corporate governance. The deadline for investors to file for lead plaintiff status is June 26, 2026.
The lawsuit further claims that SES AI touted deals with entities that lacked meaningful operations, exaggerated the capabilities and commercialization of its “Molecular Universe” AI platform, and failed to disclose material logistics issues that negatively impacted revenue. These issues culminated in a weak 2026 revenue guidance that fell well below expectations, leading to a significant stock price decline.
The truth began to emerge through a December 2025 short-seller report and subsequent disclosures, which ultimately led to the stock drop. The lawsuits aim to recover losses for investors who purchased shares during the class period.
This article is for informational purposes only and does not constitute investment advice.
